PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trial

Chia, Stephen KL; ...; Holmes, Frankie Ann; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von, Minckwitz Gunter; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; Evic, Zorica Toma; Denduluri, Neelima; Eparovic, Robert; Kim, Sung-Bae; Jakobsen, Erik Hugger; Harvey, Vernon; Robert, Nicholas; Smith, John II; Harker, Graydon; Lalani, Alshad S; Zhang, Bo; Eli, Lisa D; Buyse, Marc; (broj, koautora 25)

Rezultati

eNauka > Rezultati > PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trial

Title:	PIK3CA alterations and benefit with neratinib after trastuzumab-based adjuvant therapy in early-stage HER2+breast cancer: Correlative analyses of the phase III ExteNET trial
Authors:	Chia, Stephen KL; ...; Holmes, Frankie Ann; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von, Minckwitz Gunter; Mansi, Janine; Barrios, Carlos H; Gnant, Michael; Evic, Zorica Toma; Denduluri, Neelima; Eparovic, Robert; Kim, Sung-Bae; Jakobsen, Erik Hugger; Harvey, Vernon; Robert, Nicholas; Smith, John II; Harker, Graydon; Lalani, Alshad S; Zhang, Bo; Eli, Lisa D; Buyse, Marc; (broj, koautora 25);
Issue Date:	2018
Publication:	CANCER RESEARCH
ISSN:	0008-5472 Cancer Research Search Idenfier
Type:	Conference Paper
Collation:	vol. 78 br. 4
WoS-ID:	000425489402242
URI:	https://enauka.gov.rs/handle/123456789/813068
Metadata source:	(Preuzeto iz Nasi u WoS)
M-category:	Mp. category will be shown later

Pronađi DOI

Pronalaženje DOI u servisu CrossRef-u na osnovu meta-podataka u zapisu. Prikazaće se DOI (i metapodaci) čiji se podaci najviše poklapaju. OPREZ - to ne mora biti ta publikacija.

Google Scholar^TM

Rezultati na eNauka su zaštićeni autorskim pravima i sva prava su zadržana, osim ako nije drugačije naznačeno.